Browse > Article
http://dx.doi.org/10.5734/JGM.2011.8.1.53

Association of a c.1084A>G (p.Thr362Ala)Variant in the DCTN4 Gene with Wilson Disease  

Lee, Robin Dong-Woo (Bel Air High School)
Kim, Jae-Jung (Asan Institute for Life Sciences, University of Ulsan College of Medicine)
Kim, Joo-Hyun (Asan Institute for Life Sciences, University of Ulsan College of Medicine)
Lee, Jong-Keuk (Asan Institute for Life Sciences, University of Ulsan College of Medicine)
Yoo, Han-Wook (Asan Institute for Life Sciences, University of Ulsan College of Medicine)
Publication Information
Journal of Genetic Medicine / v.8, no.1, 2011 , pp. 53-57 More about this Journal
Abstract
Purpose: Wilson disease is an autosomal recessive disorder which causes excessive copper accumulation in the hepatic region. So far, ATP7B gene is the only disease-causing gene of Wilson disease known to date. However, ATP7B mutations have not been found in ~15% of the patients. This study was performed to identify any causative gene in Wilson disease patients without an ATP7B mutation in either allele. Materials and Methods: The sequence of the coding regions and exon-intron boundaries of the five ATP7B-interacting genes, ATOX1, COMMD1, GLRX, DCTN4, and ZBTB16, were analyzed in the 12 patients with Wilson disease. Results: Three nonsynonymous variants including c.1084A>G (p.Thr362Ala) in the exon 12 of the DCTN4 gene were identified in the patients examined. Among these, only p.Thr362Ala was predicted as possibly damaging protein function by in silico analysis. Examination of allele frequency of c.1084A>G (p.Thr362Ala) variant in the 176 patients with Wilson disease and in the 414 normal subjects revealed that the variant was more prevalent in the Wilson disease patients (odds ratio [OR]=3.14, 95% confidence interval=1.36-7.22, P=0.0094). Conclusion: Our result suggests that c.1084A>G (p.Thr362Ala) in the ATP7B-interacting DCTN4 gene may be associated with the pathogenesis of Wilson disease.
Keywords
Wilson disease; DCTN4; ATP7B-interacting genes; Polymorphism; Association;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Tao TY, Liu F, Klomp L, Wijmenga C, Gitlin JD. The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein. J Biol Chem 2003;278:41593-6.   DOI
2 Lim CM, Cater MA, Mercer JF, La Fontaine S. Copperdependent interaction of glutaredoxin with the N termini of the copper-ATPases (ATP7A and ATP7B) defective in Menkes and Wilson diseases. Biochem Biophys Res Commun 2006;348:428-36.   DOI   ScienceOn
3 Ko JH, Son W, Bae GY, Kang JH, Oh W, Yoo OJ. A new hepatocytic isoform of PLZF lacking the BTB domain interacts with ATP7B, the Wilson disease protein, and positively regulates ERK signal transduction. J Cell Biochem 2006;99:719-34.   DOI   ScienceOn
4 Lim CM, Cater MA, Mercer JF, La Fontaine S. Copperdependent interaction of dynactin subunit p62 with the N terminus of ATP7B but not ATP7A. J Biol Chem 2006;281:14006-14.   DOI
5 Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007;56:115-20.   DOI   ScienceOn
6 van De Sluis B, Rothuizen J, Pearson PL, van Oost BA, Wijmenga C. Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum Mol Genet 2002;11:165-73.   DOI
7 Coronado VA, Bonneville JA, Nazer H, Roberts EA, Cox DW. COMMD1 (Murr1) as a candidate in patients with copper storage disease of undefined etiology. Clin Genet 2005;68:548-51.   DOI   ScienceOn
8 Stuehler B, Reichert J, Stremmel W, Schaefer M. Analysis of the human homologue of the canine copper toxicosis gene Murr1 in Wilson disease patients. J Mol Med 2004;82:629-34.
9 Lutsenko S, Tsivkovskii R, Walker JM. Functional properties of the human copper-transporting ATPase ATP7B (the Wilson's disease protein) and regulation by metallochaperone ATOX1. Ann N Y Acad Sci 2003;986:204-11.   DOI   ScienceOn
10 de Bie P, Muller P, Wijmenga C, Klomp LW. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet 2007;44:673-88.   DOI
11 Banci L, Bertini I, Cantini F, Rosenzweig AC, Yatsunyk LA. Metal binding domains 3 and 4 of the Wilson disease protein: solution structure and interaction with the copper(I) chaperone HAH1. Biochemistry 2008;47:7423-9.   DOI   ScienceOn